| Old Articles: <Older 3691-3700 Newer> |
|---|
 |
Pharmaceutical Executive
May 1, 2007
Kevin A. Schulman |
Kid Tested, Government Approved? Critics claim pharma is too richly rewarded for studying drugs in children. Now, several legislative proposals are on the table that just might change that.   |
Pharmaceutical Executive
May 1, 2007
Gregory & Giacopelli |
The Secret Corporate advertising just may be what the pharmaceutical industry needs to more positively shape the way it is viewed by a variety of audiences. |
Pharmaceutical Executive
May 1, 2007
Patrick Clinton |
The Topic of Cancer What will tomorrow's cancer commercialization model really look like? We asked four heavyweights from the world of oncology what they thought. |
Pharmaceutical Executive
May 1, 2007
Jill Wechsler |
Washington Report: Pathways for Proteins The push is on to establish an approval pathway for generic versions of biotech therapies. Innovators want exclusivity and clinical studies for follow-on biologics, but visions of billion-dollar savings may short-circuit the scientific debate. |
Pharmaceutical Executive
May 1, 2007
Weiner & Hovde |
Critical Mass for Critical Path? Everyone agrees that it's the road to pharma's future, but no one's rushing to take it. Yet with growing FDA advocacy and new advances in biomarkers and drug-disease modeling, the rewards of collaboration now look greater than the risks. |
Pharmaceutical Executive
May 1, 2007 |
Deals: Roche Goes Shopping BioVeris purchase locks in a key diagnostic technology... Eisai buys Morphotek... IMS gets more outcomes-research muscle... etc. |
Pharmaceutical Executive
May 1, 2007 |
Thoughtleader: Thomas Nagle, Strategic Pricing Group This industry consultant believes the U.S. government will soon follow Europe's lead in taking a greater hand in price negotiations, and pharma will need to be able to communicate the value that products offer. Here he discusses how pharma can meet that challenge. |
Pharmaceutical Executive
May 1, 2007
Peter Pitts |
Opinion: Are Price Controls the New Black? A revamped version of an old bill calling for drug importation is on the congressional runway. With bipartisan backing and red-hot Rahmed-up rhetoric, the legislation might just pass -- and spell failure for the future of innovative drug development. |
Pharmaceutical Executive
May 1, 2007
George Koroneos |
Marketing to Professionals: No Sales Force, No Problem Pharma companies turn to direct-mail marketing tactics to boost sales for older drugs. |
Pharmaceutical Executive
May 1, 2007 |
Alternative Media: Centocor Documentary Turns Camera on Patients Roll out the red carpet -- pharma is going Hollywood. Here is how pharma can harness movies for health education. |
| <Older 3691-3700 Newer> Return to current articles. |
